Table 2 Univariate analysis of risk factors for three-year DFS and OS.
Risk Factor | Disease-free Survival | Overall Survival | ||||
---|---|---|---|---|---|---|
3-year DFS rate (%) | HR (95% CI) | p-value | 3-year OS rate (%) | HR (95% CI) | p-value | |
AJCC Stage III | 62.2 | 4.06 (2.27–7.23) | <0.001 | 75.8 | 5.19 (2.23–12.10) | <0.001 |
AJCC Stage II | 78.7 | 2.05 (1.08–3.89) | 0.027 | 82.3 | 3.17 (1.29–7.74) | 0.012 |
Low-grade differentiation | 61.4 | 2.32 (1.37–3.93) | 0.002 | 72.5 | 4.28 (1.93–9.50) | <0.001 |
Vascular invsion | 53.1 | 2.32 (1.50–3.58) | <0.001 | 67.3 | 2.30 (1.31–4.03) | 0.004 |
Perineural invasion | 37.8 | 3.60 (2.27–5.69) | <0.001 | 70.0 | 2.41 (1.27–4.59) | 0.007 |
Distance from anal verge <5 cm | 69.4 | 1.50 (1.06–2.13) | 0.022 | 77.1 | 1.58 (1.02–2.47) | 0.043 |
Preoperative elevated CEA | 65.3 | 1.46 (1.01–2.09) | 0.044 | 71.2 | 2.22 (1.40–3.50) | 0.001 |
TTDpR | 1.13 (1.06–1.22) | 0.001 | 1.17 (1.07–1.29) | 0.001 | ||
</ = 4.5 weeks | 81.4 | 0.55 (0.29–1.04) | 0.065 | 95.8 | 0.35 (0.12–0.97) | 0.048 |
>4.5 weeks | 76.2 | 1 | 87.9 | 1 |